News Search Results
Oct 14, 2026, 10:19 ET Tsingke Customer Quality Audit Highlights Manufacturing Systems and Quality Controls
BEIJING, Oct. 14, 2026 /PRNewswire/ -- As synthetic biology expands into new applications, standardized manufacturing processes, reliable production data, and robust quality management systems are becoming increasingly important.
More news about: Tsingke Biotech
Oct 08, 2026, 06:00 ET Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Araceli Biosciences
Oct 08, 2026, 06:00 ET Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Araceli Biosciences
Oct 06, 2026, 12:07 ET AIAS+ 2026 Brings Leading Scientists to San Francisco to Explore How AI Is Changing Scientific Discovery
Chen, Breakthrough Prize in Life Sciences recipient and Professor of Molecular Biology at UT SouthwesternJames J. Collins, MIT synthetic biology pioneer and member of the National Academies of Sciences, Engineering and MedicineDaphne Koller, co-founder of Coursera and founder
More news about: Tianqiao and Chrissy Chen Institute (TCCI)
Oct 06, 2026, 11:02 ET Luminous Mind, Inc. Announces U.S. Patent for Non-Hallucinogenic Psychedelic Mushrooms
Sets the stage for developing pharmaceuticals through synthetic biologyLMI's patent recognizes that psilocybin-containing mushrooms produce other highly beneficial compounds (secondary metabolites
More news about: Luminous Mind, Inc.
Oct 06, 2026, 07:00 ET Dotmatics Luma Achieves Databricks Gold Status and Joins the Marketplace
advanced materials, agriculture, consumer products, energy, and beyond—supporting scientific workflows from drug development and genomics to synthetic biology, therapeutics, cell biology, formulations, and analytical chemistry. More than 2 million scientists and 14,000 customers across over 180
More news about: Dotmatics
Oct 01, 2026, 08:00 ET Non-GMO Project Adds Sugarcane to High-Risk List in Version 17 of its Standard
addresses emerging biotechnology. Version 17 clarifies the technologies covered by the Standard, including CRISPR and other gene editing methods, synthetic biology and precision fermentation. It also addresses newer ways of making food ingredients, including plant molecular farming and cell-free systems,
More news about: Non-GMO Project
Sep 29, 2026, 09:00 ET 10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
and broad transcriptional coverage in both tissues. Now, with three instruments planned to support research across immunology, neuroscience and synthetic biology, the Institute is preparing to take that work even further. "The Allen Institute is excited to build on our groundbreaking work with
More news about: 10x Genomics, Inc.
Sep 25, 2026, 10:30 ET Liquid Handling System Market worth $7.79 billion by 2031 - Exclusive Report by MarketsandMarkets™
laboratory platforms, and advanced dispensing technologies is further expanding the addressable market. Funding for genomics, precision medicine, synthetic biology, and advanced therapy development is encouraging laboratories to replace manual pipetting with automated and semi-automated systems that improve
More news about: MarketsandMarkets
Sep 24, 2026, 08:00 ET Minaris and Asimov Partner to Advance AAV Manufacturing with OXGENE Technology
Minaris, a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization, and Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a partnership that enables higher performing producer cell lines for production of
More news about: Minaris Advanced Therapies, LLC
Sep 23, 2026, 18:15 ET Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize Market Research
R&D, protein engineering, synthetic biology, and advanced biomanufacturing are further contributing to demand for expression vectors, reagents, competent cells, and protein production technologies.Advancements in cell-free protein synthesis, synthetic biology, protein engineering, high-throughput
More news about: Maximize Market Research Pvt. Ltd.
Sep 22, 2026, 12:08 ET Varda Space Industries Signs Steve Layne as Chief Revenue Officer and Aaron Huber as Chief Financial Officer
with nearly two decades of experience navigating the intersection of deep-tech and capital markets. His background spans automotive technology, synthetic biology, and healthcare AI, and includes a $1.6 billion NYSE listing, multiple acquisitions, and complex non-dilutive financing structures."Steve
More news about: Varda Space Industries Inc.
Sep 22, 2026, 09:07 ET Rise Therapeutics Completes Dose Escalation in R-5780 Phase 1 Cancer Trial, Advances to Dose Expansion
yet most patients either do not respond or eventually become refractory to these therapies. R-5780 is an orally delivered, precision-directed synthetic biology medicine designed to control the patient's immune system to drive a more robust anti-tumor T cell response. By resetting immunological repertoires,
More news about: Rise Therapeutics
Sep 22, 2026, 08:30 ET ERS Genomics and Sai Life Sciences Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery and Development
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals.Current ERS licensees include GSK, Merck, Bayer, Thermo Fisher
More news about: ERS Genomics
Sep 21, 2026, 22:30 ET Bestzyme Launches World's First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan
JINAN, China, Sept. 21, 2026 /PRNewswire/ -- Bestzyme, a synthetic biology company under GenScript Biotech, today announced the completion of the world's first dedicated, automated smart production line for sweet proteins at
More news about: Bestzyme
Sep 21, 2026, 09:03 ET CIIF 2026 New Material Industry Show Unveils Scenario-Driven 'Six Material Islands' Layout to Accelerate Global Supply Chain Integration
etc.5. Biomanufacturing & Life & Health: Featuring biodegradable medical materials, implantable bionics, synthetic-biology feedstocks, medical dressings, and pharmaceutical packaging.6. AI-Empowered Materials & Materials Equipment:
More news about: New Material Industry Show (NMIS)
Sep 16, 2026, 13:30 ET Frost & Sullivan and LeadLeo Identify Five Industries Shaping China's Next 50 Years of Growth
potential.Healthcare: China is moving from generic-drug-led expansion towards original innovation and greater participation in global healthcare markets. Synthetic biology, innovative drug globalisation and AI-enabled medical devices are expected to play increasingly important roles in the development of a more integrated,
More news about: Frost & Sullivan
Sep 16, 2026, 13:30 ET Frost & Sullivan and LeadLeo Identify Five Industries Shaping China's Next 50 Years of Growth
potential.Healthcare: China is moving from generic-drug-led expansion towards original innovation and greater participation in global healthcare markets. Synthetic biology, innovative drug globalisation and AI-enabled medical devices are expected to play increasingly important roles in the development of a more integrated,
More news about: Frost & Sullivan
Sep 15, 2026, 23:19 ET VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
and manufacturing vaccines and advanced biological products ("VaxThera") and Codagenix Inc., a clinical-stage biotechnology company pioneering synthetic biology-based vaccines ("Codagenix"), today announced an agreement on terms for VaxThera to exclusively license Codagenix's yellow fever vaccine candidate,
More news about: Codagenix Inc.
Sep 15, 2026, 11:00 ET IUCN Species Survival Commission and Colossal Foundation Launch $4 Million Partnership to Accelerate Global Species Conservation
IUCN policy on Synthetic Biology in relation to Nature Conservation, IUCN SSC experts will evaluate emerging conservation biotechnologies—including their potential benefits,
More news about: Colossal Biosciences Inc.
Aug 31, 2026, 10:15 ET Oligonucleotide CDMO Market worth $11.14 billion by 2031 - Exclusive Report by MarketsandMarkets™
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue
More news about: MarketsandMarkets
Aug 27, 2026, 13:37 ET Lynn L. Bergeson Earns Highest Accolades from Chambers and Partners and Best Lawyers
regulation, the Food Quality Protection Act (FQPA), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Ms. Bergeson is a tireless and dynamic advocate for clients commercializing new chemicals with
More news about: Bergeson & Campbell, P.C.
Aug 18, 2026, 10:00 ET GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
performance and building an order base that supports future revenue growth. Bestzyme continues to invest in enzyme engineering and AI-enabled synthetic biology technologies designed to improve research efficiency, reduce production costs, and accelerate new product development.OutlookGenScript
More news about: GenScript Biotech Corporation
Aug 18, 2026, 10:00 ET GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
performance and building an order base that supports future revenue growth. Bestzyme continues to invest in enzyme engineering and AI-enabled synthetic biology technologies designed to improve research efficiency, reduce production costs, and accelerate new product development.OutlookGenScript
More news about: GenScript Biotech Corporation
Aug 14, 2026, 10:15 ET IVD Raw Material Market worth $31.1 billion by 2031 - Exclusive Report by MarketsandMarkets™
development is enhancing the accuracy, sensitivity, and reliability of in vitro diagnostic tests. In parallel, advancements in recombinant technology, synthetic biology, and protein engineering are expanding the availability of highly specific and consistent raw materials for immunodiagnostic and molecular diagnostic
More news about: MarketsandMarkets